Yigeng Feng

414 citations
27 papers · 291 indexed · h-index 9
Topics
Prostate Cancer Treatment and Research (10 papers)Cancer, Lipids, and Metabolism (6 papers)MicroRNA in disease regulation (5 papers)
Partner nations
China

In The Last Decade

Yigeng Feng

26 papers receiving 288 citations

Peers

Yigeng Feng
Comparison fields: 5 of 54
  • Molecular Biology 208
  • Cancer Research 143
  • Pulmonary and Respiratory Medicine 67
  • Oncology 46
  • Immunology 32
Replace Zhendong Deng with:
Zhendong Deng China
Yongxiang Yin China
Yinji Jin China
Changjiang Lei China
Magdy K. Abdelghany United Kingdom
Tuo Ruan China
Waraporn Chan-on Thailand
Yigeng Feng relative to Zhendong Deng China Zhendong Deng's profile →
Citations per field
00.5×4.6×
Zhendong Deng · 1×
Citations per year

Countries citing papers authored by Yigeng Feng

Since Specialization
Citations

This map shows the geographic impact of Yigeng Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yigeng Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yigeng Feng more than expected).

Fields of papers citing papers by Yigeng Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yigeng Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yigeng Feng. The network helps show where Yigeng Feng may publish in the future.

Co-authorship network of co-authors of Yigeng Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Yigeng Feng. A scholar is included among the top collaborators of Yigeng Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yigeng Feng. Yigeng Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 2
4 6
5 5
6 1
7 4
8 1
9 13
10 8
11 4
12
RNA-seq reveals microRNA-302b as a suppressor of prostate cancer epithelial-mesenchymal transition by targeting RELA/NF-κB.
2
13 9
14 19
15 31
16 8
17 4
18 51
19 34
20 49

About Yigeng Feng

Yigeng Feng is a scholar working on Cancer Research, Biological Psychiatry and Pulmonary and Respiratory Medicine, having authored 27 papers that have together received 291 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (10 papers), Cancer, Lipids, and Metabolism (6 papers) and MicroRNA in disease regulation (5 papers). The work is most often cited by research in Cancer Research (143 citations), Molecular Medicine (24 citations) and Molecular Biology (208 citations). Yigeng Feng has collaborated with scholars based in China. Frequent co-authors include Hongwen Cao, Lei Chen, Chao Yu, Lei Chen, Liang Fang, Xiaofeng He, Dan Wang, Dan Wang, Dongwen Gao and Lei Chen. Their work appears in journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Biomedicine & Pharmacotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026